Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VYGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VYGR

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Voyager Therapeutics Inc

VYGR
Current price
3.20 USD 0 USD (0.00%)
Last closed 3.20 USD
ISIN US92915B1061
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 177 076 480 USD
Yield for 12 month -58.92 %
1Y
3Y
5Y
10Y
15Y
VYGR
21.11.2021 - 28.11.2021

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts. Address: 75 Hayden Avenue, Lexington, MA, United States, 02421

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.78 USD

P/E Ratio

Dividend Yield

Financials VYGR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VYGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+80 001 000 USD

Last Year

+250 008 000 USD

Current Quarter

+6 473 000 USD

Last Quarter

+6 278 000 USD

Current Year

+80 001 000 USD

Last Year

+245 567 000 USD

Current Quarter

+6 473 000 USD

Last Quarter

+6 278 000 USD
EBITDA -94 472 000 USD
Operating Margin TTM -535.97 %
Price to Earnings
Return On Assets TTM -15.04 %
PEG Ratio
Return On Equity TTM -27.61 %
Wall Street Target Price 15.78 USD
Revenue TTM 66 958 000 USD
Book Value 4.94 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -66.80 %
Dividend Yield
Gross Profit TTM -62 068 000 USD
Earnings per share -1.46 USD
Diluted Eps TTM -1.46 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -126.49 %

Stock Valuation VYGR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.14
Price Sales TTM 2.64
Enterprise Value EBITDA 2.59
Price Book MRQ 0.65

Technical Indicators VYGR

For 52 Weeks

2.65 USD 9.55 USD
50 Day MA 3.24 USD
Shares Short Prior Month 3 197 363
200 Day MA 4.85 USD
Short Ratio 5.34
Shares Short 3 918 856
Short Percent 8.45 %